Itamar Medical Ltd. is a publicly traded medical device company (TASE:ITMR) based in Israel’s Caesarea Industrial Park that develops non-invasive medical devices using the proprietary PAT™ (Peripheral Arterial Tone) signal.
Since its founding in 1997, the Company has engaged in research and development of non-invasive medical devices for diagnosis of various medical conditions, including cardiovascular disease and respiratory disorders.
The first two product lines from Itamar Medical, based on unique technology developed by the Company, are the WatchPAT™ home appliance for respiratory sleep disorder diagnosis, and EndoPAT™, the only device approved by the FDA for testing endothelial (arterial) function and assessing the risk of coronary artery disease and other cardiovascular diseases.
Read more about Itamar Medical at the Company Profile:
Commitment to Quality:
Itamar Medical is committed to delivering the highest levels of quality and customer satisfaction. At Itamar Medical quality is a priority, requiring management and employees at all levels to continuously strive for excellence and improvement.
Itamar Medical complies with international standards of quality (ISO 9001, ISO 13485).